Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 25, 2022Digestive Endoscopy

First dose‐ranging study of remimazolam in Japanese patients undergoing gastrointestinal endoscopy: Phase II investigator‐initiated clinical trial

View Full Paper
Ask AI
Bookmark
Share

Authors

RIRyoji IchijimaHIHisatomo IkeharaTMTakeshi Maeda

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ichijima et al. (2022) studied this question.

synapsesocial.com/papers/6a21ead3e8ef4064f24e949ehttps://doi.org/10.1111/den.14365
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Speed of reversal of midazolam‐induced respiratory depression by flumazenil ‐ a study in patients undergoing upper G.I. endoscopy1990 · 39 citations
  2. 2Flumazenil reversal of psychomotor impairment due to midazolam or diazepam for conscious sedation for upper endoscopy1996 · 46 citations
  3. 3A Postanesthetic Recovery Score1970 · 1,126 citations
  4. 4Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial2020 · 284 citations
  5. 5Sedation outcomes for remimazolam, a new benzodiazepine2021 · 105 citations